Sightera Biosciences
Sightera Biosciences is a Belgian techbio company using generative AI to develop novel small-molecule therapies.
Sightera Biosciences has raised €3.0M across 1 funding round from 3 investors, most recently a Pre-Seed round in Jul 2026. Based in Antwerp, Belgium; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.0M
€3,000,000
Funding rounds
1
Investors
3
distinct backers
Active since
2026-07
latest 2026-07
Funding by year
EUR raised per year · 2026 YTDSightera Biosciences — funding by year — interactive chart.
Data table
| Sightera Biosciences — funding by year | |
|---|---|
| 2026 | €3.0M |
Signals
High confidenceRaise-next likelihood15
base rate 24% for Pre-Seed
- ▼ Raised very recently
- ▼ Low backer re-investment
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-07-17 | Pre-Seed | €3.0M | Anacura,Entourage,Qbic | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData